Zydus Wellness Q2 Results Live: Zydus Wellness declared its Q2 results on November 11, 2024, showing impressive financial growth. The company’s top line grew 12.05% year-over-year, while profit rose 254.24%. This significant increase in profit reflects the company’s strong operating performance and market positioning.

However, comparing the results to the previous quarter, Zydus Wellness saw a decline in both revenue and profit, with revenue down 41.39% and profit down 85.85%. This quarterly comparison highlights the volatility of the company’s performance and the need for sustained growth.

The company’s selling, general and administrative expenses were down a respectable 37.07% quarter over quarter, but up 16.77% year over year. This indicates a concentrated effort to manage costs effectively in the current economic environment.

Operating income also faced a sizeable decline of 90.21% from the previous quarter, but saw a year-on-year increase of 36.11%. This contrasting performance suggests that while the company faces near-term challenges, there are underlying strengths driving year-over-year growth.

Earnings per share (EPS) for Q2 is at ₹2.46, reflecting a robust year-on-year growth of 164.89%. This performance metric is a positive indicator for investors looking at the company’s profitability.

In terms of market performance, Zydus Wellness has returned -1.18% in the last week but more encouraging return of 14.41% in past six months and 14.78% year to date return. These numbers demonstrate the stock’s resilience in fluctuating market conditions.

Currently, Zydus Wellness has a market capitalization of ₹12,278.46 crore with a 52-week high of ₹2,484 and a minimum of ₹1,440.15. This range highlights the volatility and upside potential of the company’s stock.

As of November 12, 2024, out of five analysts covering Zydus Wellness, two have given a “Hold” rating, while three analysts have recommended a “Buy”. The consensus recommendation indicates a positive outlook for the company, indicating investor confidence in its future performance.

Zydus Wellness Financials